Printer Friendly
The Free Library
19,573,962 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

[0] CEO INTERVIEW: IAN SMITH - VERTEX PHARMACEUTICALS INC (VRTX).


(PAL200) IAN SMITH - VERTEX PHARMACEUTICALS INC (VRTX An earlier real time operating system for embedded systems from Mentor Graphics, Wilsonville, OR (www.mentor.com). VRTX was the progenitor of the VxWorks OS from Wind River and was superseded by Nucleus OS.

VRTX - Virtual Real-Time Executive.
). Describes the company's business and its background; prospects for the industry, with positive and negative trends; competitive threats; strategic opportunities for the firm including its marketing plans and acquisition potential; management strength and organization; and the financial prospects of the firm looking forward. Sector: Biotechnology. Published date 6/2/02. Tickers featured: VRTX. Complete text approximately 3000 words. Document # PAL200.

CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: transcript@twst.com.

***
COPYRIGHT 2002 Wall Street Transcript Corporation
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Comment:[0] CEO INTERVIEW: IAN SMITH - VERTEX PHARMACEUTICALS INC (VRTX).(Brief Article)
Publication:Wall Street Transcript Digest
Article Type:Brief Article
Geographic Code:1USA
Date:Jun 10, 2002
Words:89
Previous Article:CEO INTERVIEW: THOMAS OKARMA - GERON CORPORATION (GERN).
Next Article:CEO INTERVIEW: DENIS GADBOIS - MEDIAGRIF INTERACTIVE TECHNOLOGIES INC (MDF:TSE).
Topics:



Related Articles
JOSHUA BOGER - VERTEX PHARMACEUTICALS INC (VRTX).
Vertex Pharmaceuticals CEO Interviews On RadioWallStreet.com.
CEO INTERVIEW: IAN SMITH - VERTEX PHARMACEUTICALS INC (VRTX).
Vertex secures hepatitis C license agreement.
CYSTIC FIBROSIS FOUNDATION AWARDS $21 MILLION TO VERTEX.
VERTEX/MITSUBISHI TO DEVELOP HCV ORAL PROTEASE INHIBITOR.
VERTEX LICENSES VX-944 TO AVALON FOR CANCER TREATMENT.
ONE IDEA.
VERTEX REPORTS 2007 3RD QTR NET LOSS OF $107 MILLION.
Who's Buying Now?

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles